Lysophosphatidylinositol-glucagon like peptide 1 crosstalk in metabolic diseases

QR Code

Lysophosphatidylinositol-glucagon like peptide 1 crosstalk in metabolic diseases

This PhD thesis discusses the study of a novel class of drugs for the treatment of metabolic diseases. We have characterized the pharmacology and biology of the lipid Oleoyl-lysophosphatidylinositol (Oleoyl-LPI), and we show that some synthetic molecules mimicking its structure, are efficient glucag...

Full description

Bibliographic Details
Main Author:	Paternoster, Silvano
Format:	Thesis
Published:	Curtin University 2020
Online Access:	http://hdl.handle.net/20.500.11937/81689

Similar Items

Dissecting the physiology and pathophysiology of glucagon-like peptide-1
by: Paternoster, Silvano, et al.
Published: (2018)

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.
by: Arifin, S., et al.
Published: (2018)

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119
by: Ahmad Arifin, Syamsul, et al.
Published: (2018)

Lysophosphatidylinositol signalling and metabolic diseases
by: Ahmad Arifin, Syamsul, et al.
Published: (2016)

Lysophosphatidylinositol Signalling and Metabolic Diseases
by: Arifin, S., et al.
Published: (2016)

Determining the effect of glucagon-like peptide 1 (GLP-1) upon skeletal muscle metabolism and blood flow in older age
by: Jandova, Tereza
Published: (2017)

Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment
by: Rasouli, Mina, et al.
Published: (2011)

An examination into the effects of very-low calorie diets and glucagon-like peptide-1 receptor agonists, individually or in combination, on skeletal muscle metabolism and glycaemic outcomes in individuals with type 2 diabetes living with obesity
by: Anyiam, Oluwaseun
Published: (2025)

The gut hormone, Glucagon-Like Peptide 2, contributes to the improved glycaemic control observed post-bariatric surgery, as a result of its intestinotrophic effects
by: Rudge, Eleanor J.M.
Published: (2020)

Crosstalk between p53 and mitochondrial metabolism
by: Itahana, K., et al.
Published: (2014)

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents with Type 1 Diabetes
by: Siafarikas, A., et al.
Published: (2012)

Role of the Lysophosphatidylinositol/GPR55 axis in cancer
by: Falasca, Marco, et al.
Published: (2015)

Lysophosphatidylinositol signalling: New wine from an old bottle
by: Piñeiro, R., et al.
Published: (2012)

Cellular crosstalk mechanism of Toll-like receptors in gingival overgrowth (review)
by: Subramani, Tamilselvan, et al.
Published: (2015)

Inhibition of the lysophosphatidylinositol transporter abcc1 reduces prostate cancer cell growth and sensitizes to chemotherapy
by: Emmanouilidi, Aikaterini, et al.
Published: (2020)

The Sec14 superfamily and mechanisms for crosstalk between lipid metabolism and lipid signaling
by: Bankaitis, V., et al.
Published: (2010)

Crosstalk between fatty acid metabolism and tumour-associated macrophages in cancer progression
by: Zaidi, Noorzaileen Eileena, et al.
Published: (2022)

Molecular crosstalk
by: Hakeem, Khalid Rehman, et al.
Published: (2013)

Formulation Development and Optimization for Transdermal Delivery of Peptide and Peptide Like Drugs
by: Jhanker, Yeakuty Marzan
Published: (2018)

Crosstalk in stereoscopic displays
by: Woods, Andrew J.
Published: (2013)

Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
by: Ruban, Emily L., et al.
Published: (2014)

Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
by: Ruban, E., et al.
Published: (2014)

Insulin-like peptide 3 (INSL3)
by: Anand-Ivell, Ravinder, et al.
Published: (2018)

Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases
by: Chaudhary, Priya, et al.
Published: (2023)

Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties
by: Meloni, B., et al.
Published: (2015)

Crosstalk Modelling Of Coupled Microstrip Lines
by: Chai , Ched Chang
Published: (2002)

Crosstalk Modelling Of Coupled Microstrip Lines
by: Chai, Ched Chang
Published: (2002)

Microparticles facilitate neutrophil platelet crosstalk
by: Andrews, R., et al.
Published: (2008)

Crosstalk in stereoscopic displays: A review
by: Woods, Andrew J.
Published: (2012)

Relaxin-like peptides in male reproduction: a human perspective
by: Ivell, Richard, et al.
Published: (2017)

Analytical Evaluation Of Crosstalk In A WDM Network
by: Sim, Ngee Thiam
Published: (2002)

Analytical Evaluation Of Crosstalk In A WDM Network
by: Sim, Ngee Thiam
Published: (2002)

Platelet-cancer Crosstalk: Mechanisms and Therapeutic Implications
by: Elaskalani, Omar
Published: (2019)

How are crosstalk and ghosting defined in the stereoscopic literature?
by: Woods, Andrew
Published: (2011)

Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys
by: He, S., et al.
Published: (2013)

A simple method for measuring crosstalk in stereoscopic displays
by: Weissman, M., et al.
Published: (2011)

Mesenchymal stem cell and microglia crosstalk in an inflammatory paradigm
by: Rahmat, Muhammad Zul'atfi
Published: (2013)

Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review
by: Ranneh, Yazan, et al.
Published: (2017)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

The incorporation and metabolism of amyloid-B into chylomicron-like lipid emulsions
by: James, Anthony, et al.
Published: (2003)

Cannot write session to /tmp/vufind_sessions/sess_fldbgvrfi1de596mveouimjpgq